ClinicalTrials.govpublic full text
The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
malignant mesothelioma, tremelimumab, anti-ctla-4 monoclonal antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 848198
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.